Trump Plans 200% Tariff on Generic Drug Imports by 2029, Threatening India's Pharma Exports
US President Donald Trump has announced a phased tariff plan on imported generic medicines, set to begin in August 2026. The tariffs will escalate gradually over three years, ultimately reaching 200 percent. The policy is designed to bring pharmaceutical manufacturing back to the United States. India, one of the largest suppliers of affordable generic drugs to the US, stands to be significantly affected by the move. The development also introduces fresh uncertainty into ongoing trade negotiations between the two countries.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in